United Therapeutics(UTHR) - 2024 Q2 - Quarterly Results

Exhibit 99.1 SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 31, 2024: United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended June 30, 2024. Total revenues in the second quarter of 2024 grew 20 percent year-over-year to $714.9 million, compared to$596.5 million in the second quarter of 2023. Key financial highlights include (dollars in millions, except per share data): United Therapeutics Corporation Reports Second ...